The NHS is spending £100 million a year to help people with non-insulin treated type 2 diabetes monitor their own blood sugar levels, but the process is more likely to make them depressed than provide any long term health benefits. Access the two research papers and editorial by following the links from bmj.com's Research channel. There are also Rapid Responses to these online first papers.
Self monitoring of blood glucose in type 2 diabetes
Responses
Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial
Responses
Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial
No comments:
Post a Comment